GU CONNECT Experts Knowledge Share: Incorporating PARP inhibitors into prostate cancer clinical practice

Monday, November 14th 2022
18:15
19:45
CET
12:15
13:45
EST
02:15
03:45
JST (+1 Day)

About This Meeting

A virtual Experts Knowledge Share on the topic ‘Incorporating PARP inhibitors into prostate cancer clinical practice’ chaired by Prof. Fred Saad (Canada) and co-chaired by Assoc. Prof. Tanya Dorff (USA), Prof. Gerhardt Attard (UK) and Prof. Neeraj Agarwal.

Learn about and discuss how to:

1)      Recognise the efficacy and safety profiles of PARP inhibitors for patients with prostate cancer, including an overview of the data in other tumour types

2)      Implement testing strategies to predict if a patient with prostate cancer is likely to respond to a PARP inhibitor or some other treatment

3)      Understand the data from combination studies with PARP inhibitors, their appropriate implementation in treatment strategies, and their impact on clinical practice

You will also have the opportunity to contribute to the discussion on this important topic in genitourinary oncology.  If you would like to ask the faculty a specific question, please include this on your Pre-Event Survey.

Meeting Materials

To view meeting materials, you need to be registered for the meeting.

Faculty

Prof. Fred Saad
International Urology and GU Oncology Expert
University of Montreal Hospital Center, Canada
Assoc. Prof. Tanya Dorff
Medical Oncologist
City of Hope Comprehensive Cancer Centre, USA
Prof. Gerhardt Attard
Medical Oncologist
University College London Hospital, UK
Prof. Neeraj Agarwal
Medical Oncologist
Huntsman Cancer Institute, University of Utah, USA

Faculty

Prof. Fred Saad

International Urology and GU Oncology Expert
University of Montreal Hospital Center, Canada

Assoc. Prof. Tanya Dorff

Medical Oncologist
City of Hope Comprehensive Cancer Centre, USA

Prof. Gerhardt Attard

Medical Oncologist
University College London Hospital, UK

Prof. Neeraj Agarwal

Medical Oncologist
Huntsman Cancer Institute, University of Utah, USA
GU CONNECT is an initiative of COR2ED. This programme is supported by an Independent Medical Education Grant from AstraZeneca.

COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved 
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept